Skip to main content

West Nile Virus

 


West Nile virus (WNV) is most commonly spread to people by the bite of an infected mosquito.

In humans, disease ranges from asymptomatic infection, seen frequently, to encephalitis/paralysis and death, seen rarely. 

Symptoms

No symptoms in most people. Most infected individuals  (8 out of 10) do not experience any symptoms.

Fever: About 1 in 5 infected individuals have a fever with other mild symptoms such as rash, headache, body aches, joint pains, vomiting, and diarrhea

Serious symptoms  About 1 in 150 infected individuals develop a severe illness affecting the central nervous system such as encephalitis (inflammation of the brain) or meningitis (inflammation of the membranes that surround the brain and spinal cord)

  • About 1 out of 10  people who develop severe illness affecting the central nervous system die.

You can reduce your risk of WNV by wearing long-sleeved shirts, long pants, masks, gloves and goggles to prevent mosquito bites.

Diagnostic testing:

Laboratory diagnosis is generally accomplished by testing of serum or cerebrospinal fluid (CSF) for WNV-specific IgM antibodies.

WNV-specific IgM antibodies are usually found 3 to 8 days after onset of illness and sometimes can be detected for upto 90 days or longer. Therefore, positive IgM antibodies sometimes may reflect a past infection.

Viral RNA (e.g., reverse transcriptase-polymerase chain reaction [RT-PCR]) can be performed on serum, CSF, and tissue specimens that are collected early in the course of infection.

Treatment:

  • Over-the-counter Acetaminophen, NSAIDS, other pain relievers can be used to reduce fever and relieve some symptoms
  • In severe cases, supportive treatment, such as intravenous fluids, pain medication, and nursing care is needed.

There is no FDA (Food and Drug Administration)-approved vaccine for human use, and the only recommended treatment is supportive care.

Comments

  1. Pretty good post. I just stumbled upon your blog and wanted to say that I have really enjoyed reading your blog posts. mosquito control singapore I hope you post again soon. Big thanks for the useful info.

    ReplyDelete

Post a Comment

Popular posts from this blog

Mounjaro, Is it a game changer for weight loss and diabetes?

  MOUNJARO™ ( Tirzepatide) was approved for medical use in the United States in May 2022 WEIGHT LOSS: (Not approved by FDA for weight loss) Eli Lilly and Company is  finalizing an application to the U.S. Food and Drug Administration for fast-track approval to sell tirzepatide for chronic weight management. MOUNJARO™ is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated in adults for type 2 diabetes mellitus management. CONTRAINDICATIONS Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2  Known serious all to tirzepatide or any of the excipients in MOUNJARO                                                                    ...

Thyroid health- Quality of Life

  Let's get a TSH blood test for our family and friends Normal serum TSH ranges are higher in the  people age 70 to 80 years ; based on this, higher serum TSH goals may be needed as a patient ages.  The American Thyroid Association (ATA) suggests raising the target serum TSH to 4-6 m IU/L for 70 years-old and up The thyroid is a small, butterfly-shaped hormone-producing gland located at the front of the neck. The thyroid gland secretes two main hormones:  thyroxine (T-4) and triiodothyronine (T-3).   These hormones regulate energy levels, metabolism of fats, proteins and carbohydrates, body temperature, heart rate.  Hypothyroidism happens when the underactive thyroid gland doesn't make enough hormones. Hypothyroidism affects up to 10% of the general population (5% undiagnosed) . A n autoimmune disease called Hashimoto's diseas e where our body  makes antibodies that attack healthy thyroid tissues  is the most common cause of hypothyroidism in soc...

Vaccines, XBB.1.5 variant and antibody evasion

Corona virus XBB and XBB.1 were first identified in India in mid-August and quickly became predominant in India.  The spike protein of the predominant XBB subvariant has 14 mutations in addition to those found in BA.2, including 5 in the N-terminal domain (NTD) and 9 in the receptor-binding domain (RBD), whereas XBB.1 has an additional G252V mutation. Single and combination therapies with monoclonal antibodies have received emergency use authorization for COVID-19.  Using  COVID-19 pseudovirus, which enables the study of the SARS-CoV-2 virus in cell culture,   XBB, and XBB.1 subvariants were found to have far greater antibody resistance than earlier variants. XBB sublineages are completely resistant to bebtelovimab, leaving us with no authorized antibody for treatment use. The combination of mAbs known as Evusheld that is authorized for the prevention of COVID-19 is also completely inactive against the new subvariants. This poses a serious problem for millions of im...